InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,992.68
(
-0.18%
)
Post# of 252963
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120329
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 247603

Wednesday, 07/17/2024 1:58:01 PM

Wednesday, July 17, 2024 1:58:01 PM

Post# of 252963
Re: IRA drug-price “negotiations”

JNJ said on today’s 2Q24 CC that there were no unpleasant surprises on the IRA price negotiations for Stelara and Xarelto, two of the 10 drugs subject to 2026 price negotiation.

BMY, part-owner (with PFE) of Eliquis—the largest-selling drug subject to 2026 IRA price negotiation—is +5% today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up